1,3,5-triazines (Nippon Shinyaku)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name1,3,5-triazines (Nippon Shinyaku)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsRetinal DiseasesArthritisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Shinyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsRetinal DiseasesArthritisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A